| Financial Year |
March 31 2023 |
| Monetary Funds |
413,997,827.36 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
37,585,943.25 |
| Accounts Receivable |
99,797,132.38 |
| Advances to Suppliers |
8,103,089.90 |
| Other Receivables |
3,270,924.36 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
130,990,318.69 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
21,428,970.02 |
| Total Current Assets |
870,003,845.56 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
652,727,944.62 |
| Under-construction Projects |
1,226,332,900.03 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
26,256,611.30 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
20,627,434.04 |
| Deferred Income Tax Assets |
9,528,631.81 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,935,473,521.80 |
| Total Assets |
2,805,477,367.36 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
166,581,158.00 |
| Accounts Payable |
707,166,415.62 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
35,249,616.74 |
| Taxes Payable |
9,797,726.36 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
21,207,763.50 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,340.29 |
| Other Current Liabilities |
3,014,187.86 |
| Sub-Total of Current Liabilities |
966,209,268.80 |
| Long-term Loans |
5,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,249,481.15 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
36,298,163.94 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
58,585,376.75 |
| Total Liabilities |
1,024,794,645.55 |
| Paid-In Capital(Or Share Stock) |
434,800,000.00 |
| Capital Surplus |
543,589,846.55 |
| Surplus Reserve |
106,904,923.36 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
685,846,094.79 |
| Minority Stockholder's Interest |
6,005,660.03 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,774,677,061.78 |
| Owner's Equity（Stockholder's Equity） |
1,780,682,721.81 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,805,477,367.36 |
